GRI Bio, Inc.
GRI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,581 | $26,312 | $437,239 | $90,161,756 |
| - Cash | $5,028 | $1,808 | $9 | $3,702 |
| + Debt | $119 | $14 | $673 | $169 |
| Enterprise Value | -$2,328 | $24,518 | $437,903 | $90,158,223 |
| Revenue | $22,538 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $10,910 | $0 | $0 | $0 |
| % Margin | 48.4% | – | – | – |
| EBITDA | -$8,231 | -$10,898 | -$2,514 | -$939 |
| % Margin | -36.5% | – | – | – |
| Net Income | -$8,207 | -$13,037 | -$3,217 | -$1,559 |
| % Margin | -36.4% | – | – | – |
| EPS Diluted | -55.21 | -6,242.18 | -165,346 | -815.8 |
| % Growth | 99.1% | 96.2% | -20,168% | – |
| Operating Cash Flow | -$8,611 | -$9,140 | -$1,085 | -$8,312 |
| Capital Expenditures | $0 | -$8 | -$3 | $0 |
| Free Cash Flow | -$8,611 | -$9,148 | -$1,088 | -$8,312 |